Literature DB >> 22438196

Histopathologic analysis of the internal limiting membrane surgically peeled from eyes with diffuse diabetic macular edema.

Kaoru Tamura1, Toshiyuki Yokoyama, Nobuyuki Ebihara, Akira Murakami.   

Abstract

PURPOSE: To investigate the pathogenesis of diffuse diabetic maculae edema (DME).
METHODS: Internal limiting membrane (ILM) specimens were surgically peeled from 16 eyes of 15 patients with diffuse DME (diabetic retinopathy (DR) group) and from 12 eyes of 12 patients without diabetes (non-DR group). The specimens were then examined by light microscopy (LM), transmission electron microscopy (TEM), and immunohistochemistry.
RESULTS: Examination by LM revealed numerous cells on the inner surface of the ILM specimens in the DR-group, among which five different cell types (glial cell, fibroblast-like cell, macrophages, neutrophils, and lymphocytes) were confirmed. Examination by TEM revealed that the thickness of the peeled ILMs in the DR group was significantly greater, and four types of cellular element (glial, fibroblast-like, macrophages, and lymphocytes) were confirmed on the surface of the vitreous side of the specimens. The existence of glial cells and macrophages was confirmed by immunohistochemistry.
CONCLUSIONS: In diffuse DME, the ILM is thickened and a variety of cellular elements, especially numerous kinds of inflammatory cell, adhere to the inner surface of the ILM. To attenuate diffuse DME, vitrectomy combined with ILM peeling to remove the inflammatory cells and the physical barrier might be effective.

Entities:  

Mesh:

Year:  2012        PMID: 22438196     DOI: 10.1007/s10384-012-0130-y

Source DB:  PubMed          Journal:  Jpn J Ophthalmol        ISSN: 0021-5155            Impact factor:   2.447


  27 in total

1.  Improved visual acuity following pars plana vitrectomy for diabetic cystoid macular edema and detached posterior hyaloid.

Authors:  T Ikeda; K Sato; T Katano; Y Hayashi
Journal:  Retina       Date:  2000       Impact factor: 4.256

2.  Is diabetic retinopathy an inflammatory disease?

Authors:  A P Adamis
Journal:  Br J Ophthalmol       Date:  2002-04       Impact factor: 4.638

3.  Pars plana vitrectomy with internal limiting membranectomy for refractory diabetic macular edema without a taut posterior hyaloid.

Authors:  Brett J Rosenblatt; Gaurav K Shah; Sanjay Sharma; Jeff Bakal
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2004-07-31       Impact factor: 3.117

4.  Vitrectomy for diffuse macular edema in cases of diabetic retinopathy.

Authors:  N Tachi; N Ogino
Journal:  Am J Ophthalmol       Date:  1996-08       Impact factor: 5.258

5.  Long-term follow-up after macular hole surgery with internal limiting membrane peeling.

Authors:  Christos Haritoglou; Carolin A Gass; Markus Schaumberger; Arnd Gandorfer; Michael W Ulbig; Anselm Kampik
Journal:  Am J Ophthalmol       Date:  2002-11       Impact factor: 5.258

6.  Resolution of diabetic macular edema after surgical removal of the posterior hyaloid and the inner limiting membrane.

Authors:  A Gandorfer; E M Messmer; M W Ulbig; A Kampik
Journal:  Retina       Date:  2000       Impact factor: 4.256

7.  Expression profiles of cytokines and chemokines in vitreous fluid in diabetic retinopathy and central retinal vein occlusion.

Authors:  Yukihiko Suzuki; Mitsuru Nakazawa; Kaori Suzuki; Hitoshi Yamazaki; Yasuhiro Miyagawa
Journal:  Jpn J Ophthalmol       Date:  2011-05-03       Impact factor: 2.447

8.  Indocyanine green-assisted peeling of the internal limiting membrane may cause retinal damage.

Authors:  A Gandorfer; C Haritoglou; C A Gass; M W Ulbig; A Kampik
Journal:  Am J Ophthalmol       Date:  2001-09       Impact factor: 5.258

9.  Morphometry of surgically removed internal limiting membrane during vitrectomy in diabetic macular edema.

Authors:  Jan Kalvoda; Jaroslava Dusková; Ales Kubena; Ctibor Povýsil; Bohdana Kalvodová
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2009-05-09       Impact factor: 3.117

10.  Vascular endothelial growth factor in ocular fluid of patients with diabetic retinopathy and other retinal disorders.

Authors:  L P Aiello; R L Avery; P G Arrigg; B A Keyt; H D Jampel; S T Shah; L R Pasquale; H Thieme; M A Iwamoto; J E Park
Journal:  N Engl J Med       Date:  1994-12-01       Impact factor: 91.245

View more
  11 in total

1.  Three-dimensional imaging of the inner limiting membrane folding on the vitreomacular interface in diabetic macular edema.

Authors:  Sachi Abe; Teiko Yamamoto; Yoshiko Kashiwagi; Eriko Kirii; Sakiko Goto; Hidetoshi Yamashita
Journal:  Jpn J Ophthalmol       Date:  2013-10-11       Impact factor: 2.447

Review 2.  Possible roles of anti-type II collagen antibody and innate immunity in the development and progression of diabetic retinopathy.

Authors:  Tsunehiko Ikeda; Kimitoshi Nakamura; Teruyo Kida; Hidehiro Oku
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2021-08-11       Impact factor: 3.535

3.  Vision-related quality of life and visual function following intravitreal bevacizumab injection for persistent diabetic macular edema after vitrectomy.

Authors:  Yoshifumi Okamoto; Fumiki Okamoto; Takahiro Hiraoka; Tetsuro Oshika
Journal:  Jpn J Ophthalmol       Date:  2014-04-29       Impact factor: 2.447

4.  Histopathologic and electron microscopic features of internal limiting membranes in maculopathies of various etiologies.

Authors:  Mozhgan Rezaei Kanavi; Masoud Soheilian
Journal:  J Ophthalmic Vis Res       Date:  2014-04

Review 5.  Surgical Versus Medical Treatment for Diabetic Macular Edema: A Review.

Authors:  Nicolás Crim; Raúl Velez-Montoya; Virgilio Morales-Canton
Journal:  Med Hypothesis Discov Innov Ophthalmol       Date:  2017

6.  Intraretinal changes in idiopathic versus diabetic epiretinal membranes after macular peeling.

Authors:  Mario R Romano; Gennaro Ilardi; Mariantonia Ferrara; Gilda Cennamo; Davide Allegrini; Pia Clara Pafundi; Ciro Costagliola; Stefania Staibano; Giovanni Cennamo
Journal:  PLoS One       Date:  2018-05-08       Impact factor: 3.240

7.  En face image-based classification of diabetic macular edema using swept source optical coherence tomography.

Authors:  Atsushi Fujiwara; Yuki Kanzaki; Shuhei Kimura; Mio Hosokawa; Yusuke Shiode; Shinichiro Doi; Kosuke Takahashi; Ryo Matoba; Yuki Morizane
Journal:  Sci Rep       Date:  2021-04-07       Impact factor: 4.379

8.  Comparison of anatomical and functional outcomes of vitrectomy with internal limiting membrane peeling in recalcitrant diabetic macular edema with and without traction in Indian patients.

Authors:  S J Vikas; Divya Agarwal; Sankalp Seth; Aman Kumar; Atul Kumar
Journal:  Indian J Ophthalmol       Date:  2021-11       Impact factor: 1.848

Review 9.  Epiretinal membrane: optical coherence tomography-based diagnosis and classification.

Authors:  William Stevenson; Claudia M Prospero Ponce; Daniel R Agarwal; Rachel Gelman; John B Christoforidis
Journal:  Clin Ophthalmol       Date:  2016-03-29

10.  Vitreoretinal interface abnormalities in patients treatedwith ranibizumab for diabetic macular oedema.

Authors:  Yun Wong; David H W Steel; Maged S Habib; Alex Stubbing-Moore; Dalvir Bajwa; Peter J Avery
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2016-12-12       Impact factor: 3.117

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.